For congestion-linked phenotypes, natriuretic peptides (NT-proBNP) track hemodynamic improvement under SGLT2 inhibition in heart failure, although effect sizes and patterns vary by disease severity and setting [175,176]. The gene discussed is SLC5A2; the disease is heart failure.